Health
L'Oréal Announces North Asia Big Bang Beauty Tech Innovation Program Winners with Innovation Showcase at China International Import Expo
* "L'Oréal North Asia Big Bang Beauty Tech Innovation Program" (Big Bang) announced 17 innovative companies fromChina, Japan, Korea as 2023 Winners * First regional beauty tech innovation incubation exhibition unveiled at China International Import Expo featuring 16 overseas Big Bang finalist...
2023-11-06 15:00
2043
The Farrer Park Company Pte Ltd Appoints Ms Kelly Yang as Chief Executive Officer of Farrer Park Hospital
SINGAPORE, Nov. 6, 2023 /PRNewswire/ -- The Farrer Park Company Pte Ltd is pleased to announce the appointment of MsKelly Yang as the Chief Executive Officer (CEO) of Farrer Park Hospital (FPH). Ms Yang will succeed DrTimothy Low , the outgoing CEO, who is leaving to pursue other healthcare ventur...
2023-11-06 12:27
1988
Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D
SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the safety, pharmacokinetics (PK), and pharmacodynamics (PD) data of ASC42, a novel farnesoid X receptor (FXR) agonist, in healthy subjects ha...
2023-11-06 12:20
1861
David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep
LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer,
distributor, and retailer of premium bedding products worldwide, has today
announced the signing ofDavid Beckham as its newest brand ambassador.
2023-11-06 11:00
1845
David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep
LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer,
distributor, and retailer of premium bedding products worldwide, has today
announced the signing ofDavid Beckham as its newest brand ambassador.
2023-11-06 11:00
3676
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug...
2023-11-06 09:11
1489
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data
SHENZHEN, China, Nov. 6, 2023 /PRNewswire/ -- Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a mem...
2023-11-06 09:00
2131
PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association
SEOUL, South Korea, Nov. 5, 2023 /PRNewswire/ -- With much anticipation surrounding its impending release, PillWork officially announces its launch scheduled for the end of 2023. An integral part of this excitement is the company's crucial alliance with the esteemed Precision Nutrition Associatio...
2023-11-06 09:00
1360
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...
2023-11-06 08:00
2810
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy
SHANGHAI, Nov. 4, 2023 /PRNewswire/ -- On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clin...
2023-11-05 08:00
2447
Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America
Pierre Fabre Laboratories to Acquire from Atara Biotherapeutics Commercialization Rights to EBVALLO® in the United States, Canada and All Remaining Markets Pierre Fabre Laboratories to Take Over All Manufacturing, Clinical, and Regulatory Activities for EBVALLO® Following Transition Period This...
2023-11-04 00:52
1958
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023
PHILADELPHIA, Nov. 3, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy of Cancer 38th Annual Meeting (SITC 2023), to be held in San Diego and ...
2023-11-03 21:00
2114
FEBICO Makes Strides at Vitafoods Asia, Showcasing Ambitions in Asia
TAIPEI, Nov. 3, 2023 /PRNewswire/ -- Far East Bio-Tec Co., Ltd. made significant headway at this year's Vitafoods Asia exhibition held inBangkok in September. The company, under its FEBICO brand, is taking proactive steps to expand into the global market, and its progress has not gone unnoticed. ...
2023-11-03 17:00
916
Screen health: New "Eye Comfort" Certification from TÜV Rheinland
TAIPEI, Nov. 3, 2023 /PRNewswire/ -- TÜV Rheinland has launched a new "Eye Comfort" star-rating certification for testing displays. For the certification, TÜV Rheinland experts test and classify displays in terms of eye comfort within a 5-star rating system. Especially for people who spend a lot ...
2023-11-03 14:26
1570
Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia
SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- Mediwave, an emerging leader in healthcare technology, marked a significant milestone with the introduction of its cutting-edge end-to-end Emergency Response suite and the Smart Connected Ambulance, featuring AI and Mixed Reality technology inMalaysia. This...
2023-11-03 13:59
1485
The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan
HAIKOU, China, Nov. 3, 2023 /PRNewswire/ -- On 31st Oct., the 2nd Boao International Conference on Real World Studies of Medical Products, held in Boao,Hainan, was attended by nearly 1,000 participants from domestic and international pharmaceutical regulatory agencies, academic societies, indust...
2023-11-03 12:10
768
ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM
SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from three clinical studies of lisaft...
2023-11-03 09:15
736
ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting
SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from multiple clinical studies of the ...
2023-11-03 09:10
663
FWD Group announces robust growth momentum in new business highlights
HONG KONG, Nov. 3, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced new business highlights[1] for the nine months ended 30 September 2023. New business sales grew 22 percent[2] to US$1,253 million. Value of new business increased toUS$724 million, ...
2023-11-03 08:12
26885
The Sixth CIIE is ready to welcome the world
SHANGHAI, Nov. 3, 2023 /PRNewswire/ -- A total of 154 countries, regions and
international organizations have confirmed their participation in the sixth
edition of China International Import Expo (CIIE), which will take place from
Nov 5 to 10 in Shanghai.
2023-11-03 08:00
1732
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 292 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10154
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7512
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6227
